• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流行病学:疾病关联以及高密度脂蛋白相关生物标志物的调节因素

Epidemiology: disease associations and modulators of HDL-related biomarkers.

作者信息

Savolainen Markku J

机构信息

Department of Internal Medicine, Institute of Clinical Medicine, University of Oulu, Kajaanintie 50, 5000, 90014, Oulu, Finland,

出版信息

Handb Exp Pharmacol. 2015;224:259-83. doi: 10.1007/978-3-319-09665-0_7.

DOI:10.1007/978-3-319-09665-0_7
PMID:25522991
Abstract

Epidemiological studies have shown an inverse association between high-density lipoprotein cholesterol (HDL-C) levels and risk of ischemic heart disease. In addition, a low level of HDL-C has been shown to be a risk factor for other diseases not related to atherosclerosis. However, recent studies have not supported a causal effect of HDL-C in the development of atherosclerosis. Furthermore, new drugs markedly elevating HDL-C levels have been disappointing with respect to clinical endpoints. Earlier, most studies have focused almost exclusively on the total HDL-C without regard to the chemical composition or multiple subclasses of HDL particles. Recently, there have been efforts to dissect the HDL fraction into as many well-defined subfractions and individual molecules of HDL particles as possible. On the other hand, the focus is shifting from the structure and composition to the function of HDL particles. Biomarkers and mechanisms that could potentially explain the beneficial characteristics of HDL particles unrelated to their cholesterol content have been sought with sophisticated methods such as proteomics, lipidomics, metabonomics, and function studies including efflux capacity. These new approaches have been used in order to resolve the complex effects of diseases, conditions, environmental factors, and genes in relation to the protective role of HDL but high-throughput methods are still needed for large-scale epidemiological studies.

摘要

流行病学研究表明,高密度脂蛋白胆固醇(HDL-C)水平与缺血性心脏病风险呈负相关。此外,低水平的HDL-C已被证明是其他与动脉粥样硬化无关疾病的危险因素。然而,最近的研究并不支持HDL-C在动脉粥样硬化发展中的因果作用。此外,显著提高HDL-C水平的新药在临床终点方面令人失望。早期,大多数研究几乎只关注总HDL-C,而不考虑HDL颗粒的化学组成或多个亚类。最近,人们努力将HDL组分尽可能分解为定义明确的亚组分和HDL颗粒的单个分子。另一方面,重点正从HDL颗粒的结构和组成转向其功能。人们已经通过蛋白质组学、脂质组学、代谢组学等复杂方法以及包括流出能力在内的功能研究,寻找可能解释HDL颗粒与其胆固醇含量无关的有益特性的生物标志物和机制。这些新方法已被用于解析疾病、状况、环境因素和基因与HDL保护作用相关的复杂影响,但大规模流行病学研究仍需要高通量方法。

相似文献

1
Epidemiology: disease associations and modulators of HDL-related biomarkers.流行病学:疾病关联以及高密度脂蛋白相关生物标志物的调节因素
Handb Exp Pharmacol. 2015;224:259-83. doi: 10.1007/978-3-319-09665-0_7.
2
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).高密度脂蛋白(HDL)相关的鞘氨醇-1-磷酸(S1P)的抗动脉粥样硬化作用。
Cardiovasc Res. 2014 Aug 1;103(3):395-404. doi: 10.1093/cvr/cvu136. Epub 2014 Jun 1.
3
High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.高密度脂蛋白亚类与非心血管、非癌症慢性炎症相关事件及心血管事件的比较:动脉粥样硬化多族裔研究
J Am Heart Assoc. 2015 Sep 14;4(9):e002295. doi: 10.1161/JAHA.115.002295.
4
Treatment options for low high-density lipoproteins.低高密度脂蛋白的治疗选择。
Curr Opin Endocrinol Diabetes Obes. 2014 Apr;21(2):134-9. doi: 10.1097/MED.0000000000000049.
5
Targeting high-density lipoproteins: update on a promising therapy.靶向高密度脂蛋白:有前途的治疗方法的最新进展。
Arch Cardiovasc Dis. 2013 Nov;106(11):601-11. doi: 10.1016/j.acvd.2013.06.052. Epub 2013 Sep 25.
6
The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.苯巴比妥对血清高密度脂蛋白亚组分及载脂蛋白的影响。
Res Commun Chem Pathol Pharmacol. 1988 Oct;62(1):125-8.
7
[Laboratory assessment of HDL heterogeneity and function].[高密度脂蛋白异质性与功能的实验室评估]
Ann Biol Clin (Paris). 2009 Jan-Feb;67(1):7-21. doi: 10.1684/abc.2008.0284.
8
Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.高密度脂蛋白功能向临床实践的转化:当前前景与未来挑战。
Circulation. 2013 Sep 10;128(11):1256-67. doi: 10.1161/CIRCULATIONAHA.113.000962.
9
Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.短期低剂量阿托伐他汀对低密度脂蛋白和高密度脂蛋白亚组分表型的影响。
Clin Exp Pharmacol Physiol. 2014 Jul;41(7):475-81. doi: 10.1111/1440-1681.12243.
10
Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins.血浆高密度脂蛋白载脂蛋白及相关蛋白的蛋白质组学研究
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):156-63. doi: 10.1161/ATVBAHA.108.179317. Epub 2009 Sep 24.

引用本文的文献

1
Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease.冠状动脉疾病患者脂质组学失调对死亡风险的预后洞察。
Clin Transl Med. 2020 Sep;10(5):e189. doi: 10.1002/ctm2.189.
2
The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.大颗粒高密度脂蛋白(HDL)水平的改善,以及推测的HDL代谢,取决于低碳水化合物饮食和体重减轻的影响。
EXCLI J. 2016 Feb 23;15:166-76. doi: 10.17179/excli2015-642. eCollection 2016.